Q3 FY2026 · ended Sep 30, 2026 · Revenue $763.72M, -0.7% YoY · Filed Nov 5, 2026
Globus Medical, Inc. (GMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $763.7 million and net income of $141.2 million. Free cash flow was $224.8 million. As of Sep 30, 2026 it held $871.2 million in cash and investments and $108.2 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GMED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Audubon, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1237831
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $763.7M | $789.6M | $759.9M | $826.4M | $769.0M |
| Operating income | $177.6M | $182.4M | $150.4M | $169.3M | $137.4M |
| Net income | $141.2M | $151.6M | $124.3M | $140.6M | $119.0M |
| Diluted EPS | $1.04 | $1.10 | $0.90 | $1.03 | $0.88 |
| Operating cash flow | $265.2M | $209.7M | $202.4M | $248.6M | $249.7M |
| Free cash flow | $224.8M | $176.6M | $162.7M | $202.4M | $213.9M |
| Total assets | $5.5B | $5.5B | $5.4B | $5.3B | $5.1B |
| Total liabilities | $731.9M | $719.7M | $707.2M | $729.5M | $696.8M |
| Stockholders' equity | $4.8B | $4.8B | $4.7B | $4.6B | $4.4B |
| Cash and investments | $871.2M | $840.5M | $799.3M | $629.1M | $35.4M |
| Total debt | $108.2M | $111.9M | $115.9M | $119.4M | $120.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 778 Globus Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.